Indian Pharma Stocks: Cheap or Not

Indian Pharma is down in the dumps and does not see any hope for a turnaround around any time soon. However, analyzing the Pharma companies namely  we were intrigued to see the valuations from a price to book perspective.  Seeing a price to book ratio in FY 19 of around 2 for companies like Dr Reddy’s, Aurobindo Pharma, Lupin, Cipla and Glenmark make it interesting at some time in the future.  Continue reading “Indian Pharma Stocks: Cheap or Not”

Indian Pharma : Time to swallow a bitter pill

Indian Pharma along with Indian IT is the most unloved sector when the market is near its all time high with the Nifty at 9,000+. We get interested in well run companies when they re available at attractive prices. The prices could be attractive from a PE multiple or attractive from a psychological level i.e. close to their 52 week lows. We found some interesting names and are looking at them as portfolio after investing the company specific issues. Continue reading “Indian Pharma : Time to swallow a bitter pill”